Proguanil Atovaquone (Malarone Pediatric) shortage status
Shortage anticipated
Source: Health Canada shortage reports · Updated Oct 28, 2026
A shortage of Proguanil Atovaquone is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A combination medicine used to prevent and treat malaria.
Products affected
0 / 5
Reports on file
13
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
MYLAN-ATOVAQUONE/PROGUANIL
250MG
100MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02402165 · Disruption of the manufacture of the drug.
Resolved
MYLAN-ATOVAQUONE/PROGUANIL
100MG
250MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02402165 · ended Oct 20, 2025 · Shortage of an active ingredient.
Resolved
TEVA-ATOVAQUONE PROGUANIL
100MG
250MG · TABLET · TEVA CANADA LIMITED
DIN 02380927 · ended Feb 5, 2025 · Disruption of the manufacture of the drug.
Resolved
ATOVAQUONE PROGUANIL
100MG
250MG · TABLET · SANIS HEALTH INC
DIN 02421429 · ended Dec 3, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-ATOVAQUONE/PROGUANIL
100MG
250MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02402165 · ended Jul 30, 2024 · Shortage of an active ingredient.
Resolved
MYLAN-ATOVAQUONE/PROGUANIL
100MG
250MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02402165 · ended Aug 18, 2023 · Disruption of the manufacture of the drug.
Resolved
MALARONE PEDIATRIC
25.0MG
62.5MG · TABLET · GLAXOSMITHKLINE INC
DIN 02264935 · ended Jun 19, 2023 · Disruption of the manufacture of the drug.
Resolved
MYLAN-ATOVAQUONE/PROGUANIL
100MG
250MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02402165 · ended Jan 12, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ATOVAQUONE PROGUANIL
100MG
250MG · TABLET · TEVA CANADA LIMITED
DIN 02380927 · ended Dec 14, 2022 · Disruption of the manufacture of the drug.
Resolved
MYLAN-ATOVAQUONE/PROGUANIL
100MG
250MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02402165 · ended Jun 21, 2022 · Demand increase for the drug.
Resolved
TEVA-ATOVAQUONE PROGUANIL
100MG
250MG · TABLET · TEVA CANADA LIMITED
DIN 02380927 · ended Nov 30, 2019 · Disruption of the manufacture of the drug.
Resolved
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS
100MG
250MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02466783 · ended Jan 11, 2019 · Delay in shipping of the drug.
Showing 12 of 13 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Proguanil Atovaquone to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Proguanil Atovaquone is classified under “ANTIMALARIALS” (ATC P01BB).
Recent changes
Oct 20, 2026
New report filed
Common questions
What is Proguanil Atovaquone used for?
A combination medicine used to prevent and treat malaria.
When will Proguanil Atovaquone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Proguanil Atovaquone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antimalarials)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.